MAR-APIXABAN

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 28d09fd167849d5b
Drug Approval Canada Name: MAR-APIXABAN
Product Name: MAR-APIXABAN
Status: Marketed
Status Date: 2022-09-21
Original Market Date: 2022-09-21
Din: 02492377
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF02 APIXABAN
Atc Name: b 01 af 02
Aig Number: 0153051002
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

APIXABAN

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

28d09fd167849d5b

Type

Standard